Hasnain Faheem
SEC-identified person · CIK 1352620 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Zeta Acquisition Corp III KURO | Director | filed 2015 - 2026 |
| Gossamer Bio, Inc. GOSS | Director · President & CEO | filed 2019 - 2026 |
| Mirati Therapeutics, Inc. mrtx | Director | filed 2019 - 2024 |
| Panacea Acquisition Corp PANA | Director | filed 2020 - 2021 |
| Tocagen Inc TOCA | Director | filed 2017 - 2019 |
| Vital Therapies INC VTL | Director | filed 2016 - 2018 |
| Receptos, Inc. RCPT | Director · President, CEO | filed 2013 - 2015 |
| Ambit Biosciences Corp AMBI | Director | filed 2013 - 2014 |
| Somaxon Pharmaceuticals, Inc. somx | Director | filed 2010 - 2013 |
| Facet Biotech Corp FACT | Director · President & CEO | filed 2008 - 2010 |
| Tercica INC TRCA | Director | filed 2008 - 2008 |
| Protein Design Labs INC/DE pdli | Director · President & CEO | filed 2008 - 2008 |
| Biogen INC. BIIB | SVP, Oncology SBU | filed 2006 - 2008 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.